V
Vikas Kumar
Researcher at University of Agriculture, Faisalabad
Publications - 60
Citations - 1173
Vikas Kumar is an academic researcher from University of Agriculture, Faisalabad. The author has contributed to research in topics: Proinflammatory cytokine & Solid lipid nanoparticle. The author has an hindex of 13, co-authored 60 publications receiving 572 citations. Previous affiliations of Vikas Kumar include Sam Higginbottom Institute of Agriculture, Technology and Sciences.
Papers
More filters
Journal ArticleDOI
Risk of colorectal cancer in inflammatory bowel diseases.
TL;DR: Many common factors influencing the onset and advancement of IBD and CRC including the alterations in gut microbiota, changes in the interleukin pathways and tumour necrosis factor are described.
Journal ArticleDOI
Antiviral effects of probiotic metabolites on COVID-19.
Firoz Anwar,Hisham N. Altayb,Fahad A. Al-Abbasi,Abdulrahman L. Al-Malki,Mohammad Amjad Kamal,Vikas Kumar +5 more
TL;DR: Multi-way options either by blocking RBD on S proteins or interaction of S protein with ACE2 receptor proteins or inhibiting RdRp to counter any effect of COVID-19 by Plantaricin molecules are presented, paving a way that can be useful in the treatment of CO VID-19 until some better option will be available.
Journal ArticleDOI
Implication of nano-antioxidant therapy for treatment of hepatocellular carcinoma using PLGA nanoparticles of rutin.
Preeti Pandey,Mahfoozur Rahman,Prakash Chandra Bhatt,Sarwar Beg,Basudev Paul,Abdul Hafeez,Fahad A. Al-Abbasi,Muhammad Nadeem,Othman A. S. Baothman,Firoz Anwar,Vikas Kumar +10 more
TL;DR: Histopathological evaluation indicated reduced incidence of hepatic nodules, necrosis formation, infiltration of inflammatory cells, blood vessel inflammation and cell swelling with RT-PLGA-NP treatment along with considerable downregulation in the levels of proinflammatory cytokines.
Journal ArticleDOI
Fabrication, optimization, and characterization of umbelliferone β-D-galactopyranoside-loaded PLGA nanoparticles in treatment of hepatocellular carcinoma: in vitro and in vivo studies
Vikas Kumar,Prakash Chandra Bhatt,Mahfoozur Rahman,Gaurav Kaithwas,Hani Choudhry,Fahad A. Al-Abbasi,Firoz Anwar,Amita Verma +7 more
TL;DR: The study successfully established the development and characterization of UFG-PLGA-NP with noticeable effect against both in vivo and in vitro models, and demonstrated that such polymer-loaded delivery systems of U FG can be a better option and can be further explored to improve the clinical outcomes against hepatic cancer.
Journal ArticleDOI
Nanomedicine in treatment of breast cancer - A challenge to conventional therapy.
Muhammad Afzal,Ameeduzzafar,Khalid Saad Alharbi,Nabil K. Alruwaili,Fahad A. Al-Abassi,Abdulrahman L. Al-Malki,Imran Kazmi,Vikas Kumar,Mohammad Amjad Kamal,Muhammad Nadeem,Muhammad Aslam,Firoz Anwar +11 more
TL;DR: The recent advancement of different surface-engineered/targeted nanomedicines that improved the drug efficacy in breast cancer are discussed.